ICB International, Inc.
BiotechnologyCalifornia, United States11-50 Employees
ICB International, Inc. is a biotechnology research company based in La Jolla, California, focused on immunology and biomedicine. It has developed a proprietary technology intended to enable permeability of the blood-brain barrier, with the aim of enabling non-invasive diagnostics and therapeutics for central nervous system diseases, including neurodegenerative, cancer, and infectious conditions. The firm positions itself within the biotechnology sector by pursuing applications that address CNS-related health challenges through its platform, and it has pursued intellectual property development, including multiple patents related to its BBB-permeable technology. The company operates in a relatively small-scope setting, serving a specialized customer base in biomedical research and clinical development, with activities described as leveraging its technology to create FDA-regulated diagnostic and therapeutic solutions. The organization is located in California and is reporting progress such as the attainment of additional patents for its BBB-permeable peptide compositions in recent history.
1-888-653-2347 
support@leadiq.com 
